Stockreport

India's Alembic Pharma posts higher Q4 profit on strong N.America sales [Reuters]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Consolidated profit rose to 1.78 billion rupees ($21.3 million) in the three months ended March 31, from 1.53 billion rupees a year earlier. Indian generic drugmakers [Read more]